'''Prazitone''' ('''AGN-511''') is a [[barbiturate]] derivative developed in the 1970s.<ref>DE Patent 1645911</ref> Unlike most barbiturates, it has little or no [[sedative]] effects, instead acting as a non-sedating [[anxiolytic]] and [[antidepressant]].<ref>[http://www.google.com/patents?id=b-srAAAAEBAJ&dq=3806596 Ross Langlands. Method for imparting anti-depressant and/or anxiolytic effects to animals. US Patent 3,806,596]</ref> The dosage range in humans is around 200â€“600&nbsp;mg, although higher doses have been used in trials for the treatment of [[depression (mood)|depression]] associated with [[Parkinson's disease]].
